Correct Answer: D. All the above
Surgical intervention in abdominal aortic aneurysm (AAA) is indicated when the risk of rupture exceeds the operative risk. The three criteria listed are all established indications per international guidelines and Indian vascular surgery practice. Size >5.5 cm in males is the traditional threshold based on the ADAM trial, where rupture risk becomes substantial. Size >5 cm in females reflects sex-specific risk stratification—women have smaller aortic diameters and higher rupture risk at smaller sizes; this is standard in Indian vascular centers. Expansion >0.5 cm in 6 months indicates rapid growth and accelerated rupture risk, regardless of absolute size, and mandates intervention. Additionally, symptomatic AAA (pain, tenderness), contained rupture, and mycotic aneurysms are absolute indications. The question tests knowledge of all three major size/growth criteria, making "All of the above" the complete answer. Indian guidelines (RNTCP-aligned vascular surgery protocols) and Bailey & Love endorse these thresholds.
Why the other options are wrong
A. Size more than 5.5 cm in males — While this is a correct indication, it is incomplete. Selecting only this option misses the sex-specific threshold for females (5 cm) and the critical growth-rate criterion (>0.5 cm/6 months). NBE tests whether students recognize that AAA management requires all three criteria, not just one. This is a partial-truth trap. B. Size more than 5 cm in females — This is also a correct indication but alone is insufficient. Students who select only this option fail to recognize the male threshold (5.5 cm) and the expansion criterion. The trap is that each option is individually true, but the question demands comprehensive knowledge of all indications. NBE rewards complete recall. C. Expansion of >0.5 cm within 6 months — Rapid expansion is indeed an indication for surgery, but choosing only this ignores the absolute size thresholds that differ by sex. Students may incorrectly assume growth rate alone determines intervention, missing that absolute size criteria are equally important. This tests whether candidates understand that both size and growth rate guide decision-making.
High-Yield Facts
- AAA surgical threshold in males: >5.5 cm (ADAM trial standard; rupture risk ~10% per year above this size)
- AAA surgical threshold in females: >5 cm (sex-specific; smaller aortic diameter = higher rupture risk at lower absolute size)
- Rapid expansion >0.5 cm in 6 months mandates surgery regardless of absolute diameter (indicates accelerated rupture risk)
- Symptomatic AAA (pain, tenderness, hypotension) is an absolute indication for emergency surgery, even if <5.5 cm
- Contained rupture and mycotic AAA are emergency surgical indications; ruptured AAA mortality ~50% even with surgery
Mnemonics
AAA Surgery Indications: 5-5-5 Rule 5.5 cm (males) | 5 cm (females) | 0.5 cm/6 months (expansion). Remember: females get 0.5 cm less because their aortas are smaller and rupture risk is higher at any given size. When to Operate on AAA Symptomatic (pain) | Large (>5.5 M, >5 F) | Expanding (>0.5/6mo) | Wound (contained rupture). Use when counseling patients on operative timing.
NBE Trap
NBE pairs each individual criterion as a separate option to test whether students recognize that AAA surgical decision-making is multifactorial—not based on size alone or growth alone. The trap is that each option is factually correct, but incomplete; only "All of the above" captures the comprehensive management algorithm taught in Indian vascular surgery training.
Clinical Pearl
In Indian practice, sex-specific thresholds are often overlooked—many surgeons default to 5.5 cm for all patients. However, a 5.2 cm AAA in a 45-year-old woman with hypertension warrants surgery, whereas a 5.3 cm AAA in a 60-year-old man may be observed with imaging surveillance. Rapid expansion (detected on serial ultrasound) is the most common reason for early intervention in asymptomatic patients and should trigger urgent vascular surgery referral.
_Reference: Bailey & Love Ch. 58 (Arterial Disease); Harrison Ch. 242 (Aortic Aneurysm); KD Tripathi Ch. 32 (Vascular Pharmacology & Surgery)_